Previous 10 | Next 10 |
BASKING RIDGE, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitled, “Non-invasive vagus nerve stimulation for primary headache: a clinical update,”...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
The following slide deck was published by electroCore, Inc. in conjunction with this Read more ...
LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / LD Micro today announced that it will be hosting ten companies over the final two weeks of July, with a group presentation in the morning, followed by private investor meetings throughout the day. "Let's be real. COVID has hampered everything o...
BASKING RIDGE, N.J., July 16, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline on July 14, 2020, the company’s cash was incorrectly stated as being as of the end of the first quarter. Note that the company ended the second quarter of 2020 with cash, cash equivalen...
Perceptron (NASDAQ: PRCP ) -15% . More news on: Perceptron, Inc., Zynex, Inc., Rigel Pharmaceuticals, Inc., Stocks on the move, , Read more ...
On a preliminary basis , electroCore (NASDAQ: ECOR ) expects Q2 revenue of $730K - 750K compared to $734K in Q1. More news on: electroCore, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
BASKING RIDGE, N.J., July 14, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited financial guidance for the second quarter and full year 2020. ȁ...
IMV (NASDAQ: IMV ) +162% rallies on COVID-19 vaccine progress. More news on: IMV Inc., VolitionRx Limited, INmune Bio, Inc., Stocks on the move, , Read more ...
gammaCore to treat asthma in coronavirus infected patients. The U.S. Food and Drug Administration (FDA) authorized the use of gammaCore for the treatment of asthma exacerbations in known or suspected COVID-19 patients. The shares of gammaCore gained over 100% value upon the emergency use authori...
News, Short Squeeze, Breakout and More Instantly...
2024-04-21 00:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile app-enabled product for general wellness, Truvaga Plus, which will be available on www...
2024-04-01 04:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...